Detalles de la búsqueda
1.
NOD/Scid IL2Rγnull Mice Reconstituted with PBMCs from Patients with Atopic Dermatitis or Psoriasis Vulgaris Reflect the Respective Phenotype.
JID Innov;
4(3): 100268, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38736522
2.
Baricitinib Improvement Across Regions in Atopic Dermatitis Patients with Baseline Body Surface Area up to 40% and Severe Itch.
Dermatol Ther (Heidelb);
2024 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38777937
3.
Italian S3-Guideline on the treatment of Atopic Eczema - Part 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Environmental Dermatology (SIDAPA).
Ital J Dermatol Venerol;
159(3): 223-250, 2024 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38727633
4.
Italian S3-Guideline on the treatment of Atopic Eczema - First Update, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA).
Ital J Dermatol Venerol;
159(3): 279-284, 2024 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38727635
5.
Italian S3-Guideline on the treatment of Atopic Eczema - Part 2: non-systemic treatments and treatment recommendations for special AE patient populations, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA).
Ital J Dermatol Venerol;
159(3): 251-278, 2024 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38727634
6.
Real-world effectiveness and tolerability of a cream containing postbiotic Aquaphilus dolomiae extract-G3 in subjects with sensitive facial skin.
Eur J Dermatol;
34(1): 79-88, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38557463
7.
Skin Barrier Function Assessment: Electrical Impedance Spectroscopy Is Less Influenced by Daily Routine Activities Than Transepidermal Water Loss.
Ann Dermatol;
36(2): 99-111, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38576248
8.
Obesity is linked to disease severity in moderate to severe atopic dermatitis-Data from the prospective observational TREATgermany registry.
J Eur Acad Dermatol Venereol;
2024 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38661511
9.
Treatment of moderate-to-severe atopic dermatitis with baricitinib: Results from an interim analysis of the TREATgermany registry.
J Eur Acad Dermatol Venereol;
2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38545850
10.
The Burden of Pediatric Atopic Dermatitis: Quality of Life of Patients and Their Families.
J Clin Med;
13(6)2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38541925
11.
Correction to: OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target.
Am J Clin Dermatol;
25(3): 463, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38340153
12.
S3-Leitlinie Atopische Dermatitis: Teil 2 - Systemische Therapie: S3 guideline Atopic dermatitis: Part 2 - Systemic treatment.
J Dtsch Dermatol Ges;
22(2): 307-322, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38361206
13.
OX40 in the Pathogenesis of Atopic Dermatitis-A New Therapeutic Target.
Am J Clin Dermatol;
25(3): 447-461, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38236520
14.
A large language model artificial intelligence for patient queries in atopic dermatitis.
J Eur Acad Dermatol Venereol;
38(6): e531-e535, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38168874
15.
S3 Guideline Atopic dermatitis: Part 1 - General aspects, topical and non-drug therapies, special patient groups.
J Dtsch Dermatol Ges;
22(1): 137-153, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38171719
16.
Treat-to-target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitis.
J Eur Acad Dermatol Venereol;
38(1): 42-51, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37700595
17.
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1.
Am J Clin Dermatol;
25(1): 139-148, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37804473
18.
Baricitinib treatment rapidly improves the four signs of atopic dermatitis assessed by Eczema Area and Severity Index (EASI) clinical subscores.
J Eur Acad Dermatol Venereol;
38(4): 695-702, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38041556
19.
Atopic dermatitis: A global health perspective.
J Eur Acad Dermatol Venereol;
38(5): 801-811, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38151270
20.
S3 guideline Atopic dermatitis: Part 2 - Systemic treatment.
J Dtsch Dermatol Ges;
22(2): 307-320, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38161245